MobiHealth News January 21, 2020
Dexcom CEO Kevin Sayer has seen the company through some boom years, including growth that has outpaced the company’s manufacturing capabilities. But they’ve learned lessons and are pressing on with a new, smaller sensor in 2021.
One of the biggest digital health success stories of the two decades is in the diabetes space, especially the continuous glucose monitor (or CGM). The first CGM was approved by the FDA in 1999, but in the last decade we’ve seen CGMs become smaller, longer lasting and more comfortable, and we’ve seen huge strides in datasharing as CGM-phone connectivity went from novelty to commodity.
Dexcom has been one of the undisputed leaders in this trend — it was the first company to get...